Richard J. Berman - 13 Jun 2024 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Director
Signature
/s/ Alex Levit, Attorney-in-Fact
Issuer symbol
CNTX
Transactions as of
13 Jun 2024
Net transactions value
$0
Form type
4
Filing time
14 Jun 2024, 07:41:42 UTC
Previous filing
21 May 2024
Next filing
28 Aug 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 13 Jun 2024 Common Stock 50,000 $1.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.